Corporate Sponsors

The American Diabetes Association gratefully recognizes the Pathway to Stop Diabetes corporate sponsors, who cumulatively have contributed more than $53.6 million to this initiative.

Founding Pathway Sponsors



Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS


Merck inventing for life


For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit and connect with us on TwitterFacebookInstagramYouTube and LinkedIn.




At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and life-changing technologies to the world—in diagnostics, medical devices, nutritionals and branded generic medicines—that create more possibilities for people at all stages of life. Today, 103,000 of us are working to help people live not just longer, but better, in the more than 160 countries we serve. Connect with us at, on Facebook at and on Twitter @AbbottCardio, @AbbottNews and @AbbottGlobal.



Dexcom, Inc., headquartered in San Diego, CA, is dedicated to developing innovative glucose sensing technology and products to help patients and healthcare providers better manage diabetes. The Dexcom G6 Continuous Glucose Monitoring (CGM) System does not require fingersticks for calibration or diabetes treatment decisions* and features simple, one-touch sensor insertion.2 The System provides exceptional accuracy with an overall MARD of 9.0%†2 and features an Urgent Low Soon alert that can warn users 20 minutes in advance of severe hypoglycemia (55 mg/dL). Dexcom is the only provider of CGM systems indicated for children ages 2 years and older. Please visit

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 
†MARD is a statistical measure of accuracy; the lower the number, the better.


Pfizer Inc.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at In addition, to learn more, please visit us on and follow us on Twitter at @Pfizer and @Pfizer_NewsLinkedInYouTube and like us on Facebook at



BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Learn more at



We at Sanofi, are there beside people in need, as a health journey partner. We aim to protect, enable and support people facing health challenges, so they can live life to its full potential. As a responsible company, we act where the needs are greatest and where we can have maximum impact.

Sanofi Genzyme brings together our Rare Diseases, Multiple Sclerosis, Oncology, Immunology, and Rare Blood Disorder franchises. Sanofi Pasteur is a world leader in vaccines, producing over a billion doses every year to immunize more than 500 million people across the globe against a number of diseases. The field of human health is undergoing profound scientific and technological change, pointing the way to major therapeutic innovations for patients. At Sanofi, innovation is in our DNA: our mission is to harness new technologies and new ways of working to find healthcare solutions all around the world.

For more information, please visit and follow us on Twitter: @Sanofi or on Facebook: SanofiUS.